Tomopath Inc. Report issue

For profit Phase 1
Founded: Boston MA United States (2018)

Organization Overview

First Clinical Trial
2019
NCT04116164
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Tomopath Inc.